Enable your JavaScript to use Numstock


Numstock » ACAD

ACAD Stock Analysis

The latest metrics for ACADIA Pharmaceuticals Inc

Value

Metric Target Value
Price / Earnings Ratio < 12.0 -23.45
Price / Book Value Ratio < 1.5 10.27
Price / Sales Ratio < 2.0 21.71
PEG Ratio < 1.0 -0.42
EV / EBITDA Ratio < 8.0 -25.25
Price / FCF Ratio Last Year < 15.0 -23.46
Price / FCF Ratio Last Quarter < 15.0 -147.9
Price / TBV Ratio Last Year < 0.7 12.33
Price / TBV Ratio Last Quarter < 0.7 9.81
Price / NCAV Ratio Last Year < 0.7 12.59
Price / NCAV Ratio Last Quarter < 0.7 10.11

Efficiency

Metric Target Value
ROE Last Year > 25.0% -60.22
ROE Last Quarter > 25.0% -7.79
ROA Last Year > 15.0% -45.39
ROA Last Quarter > 15.0% -5.48
ROTA Last Year > 20.0% -32.32
ROTA Last Quarter > 20.0% -5.93
ROIC Last Year > 20.0% -56.77
ROIC Last Quarter > 20.0% -11.81
ROCE Last Year > 20.0% -51.48
ROCE Last Quarter > 20.0% -6.43
Inventory Turnover Last Year > 4.0 50.49
Inventory Turnover Last Quarter > 4.0 13.89
Pre-tax Margin Last Year > 20.0% -138.7
Pre-tax Margin Last Quarter > 20.0% -56.18
Accounts Payable Turnover Last Year > 3.0 64.89
Accounts Payable Turnover Last Quarter > 3.0 19.54
Accounts Receivable Turnover Last Year > 5.0 7.39
Accounts Receivable Turnover Last Quarter > 5.0 2.42

Health

Metric Target Value
Current Ratio Last Year > 1.5 8.83
Current Ratio Last Quarter > 1.5 12.46
Quick Ratio Last Year > 1.5 8.76
Quick Ratio Last Quarter > 1.5 12.38
Flow Ratio Last Year < 1.25 6.57
Flow Ratio Last Quarter < 1.25 5.99
Debt / Equity Ratio Last Year < 0.5 0.0
Debt / Equity Ratio Last Quarter < 0.5 0.0
Debt / EBITDA Ratio Last Year < 4.0 0.0
Debt / EBITDA Ratio Last Quarter < 4.0 0.0
Debt / NCAV Ratio Last Year < 2.0 0.0
Debt / NCAV Ratio Last Quarter < 2.0 0.0
Long-term Debt / Working Capital Ratio Last Year < 2.0 0.0
Long-term Debt / Working Capital Ratio Last Quarter < 2.0 0.0
Interest Coverage Ratio Ratio Last Year > 8.0 46.27
Interest Coverage Ratio Last Quarter > 8.0 0.0
FCF / Sales Ratio Last Year > 8.0% -75.79
FCF / Sales Ratio Last Quarter > 8.0% -20.01

Growth

Metric Target Value
Earnings Yield > 12% -4.26
Ebit Yield Last Year > 12% -3.52
Ebit Yield Last Quarter > 12% -0.67
FCF Yield Last Year > 10% -2.39
FCF Yield Last Quarter > 10% -0.27
Forward P/E to Trailing P/E Ratio > 1.1 0.0
Operating Cash Flow / EPS Ratio Last Year > 1.2 0.67
Operating Cash Flow / EPS Ratio Last Quarter > 1.2 0.07

Dividends

Metric Target Value
Dividend Yield > 2.0% 0.0
FCF / Dividends Paid Ratio Last Year > 2.5 0.0
FCF / Dividends Paid Ratio Last Quarter > 2.5 0.0
EPS / Dividends Paid Last Year > 2.5 0.0
EPS / Dividends Paid Last Quarter > 2.5 0.0
Payout Ratio < 40.0% 0.0

Ratings

Metric Target Value
Altman Z-score Last Year ≥ 3.5 2.64
Altman Z-score Last Quarter ≥ 3.5 3.25